Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32669864 | 0.93 | FTO (0.54) | FTOCOMT | |
| SCHEMBL32669673 | 0.90 | FTO (0.44) | FTOCOMT | |
| SCHEMBL32669652 | 0.82 | FTO (0.49) | FTOCOMT | |
| SCHEMBL32669988 | 0.81 | COMT (0.52) | FTOCOMT | |
| SCHEMBL32669661 | 0.80 | FTO (0.49) | FTOCOMT | |
| SCHEMBL32669732 | 0.79 | COMT (0.34) | FTOCOMT | |
| SCHEMBL32669706 | 0.79 | COMT (0.34) | FTOCOMT | |
| SCHEMBL32669806 | 0.78 | FTO (0.45) | FTOCOMT | |
| SCHEMBL32669528 | 0.78 | FTO (0.45) | FTOCOMT | |
| SCHEMBL32669701 | 0.77 | FTO (0.62) | FTOCOMT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260035341-A1 | FTO INHIBITORS | RPXDS CO LTD (CN) | 2026-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260035341-A1 | FTO INHIBITORS | FTO, LDLR, GPR119 | FTO 1/4885COMT 52/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.